Healthy Extracts (HYEX) Free Cash Flow Growth (1y) (2016 - 2025)
Healthy Extracts (HYEX) Free Cash Flow Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 44.93% |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 779.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 779.11% |
| Sep 30, 2025 | -635.32% |
| Jun 30, 2025 | -89.82% |
| Mar 31, 2025 | 220.56% |
| Dec 31, 2024 | -24.71% |
| Sep 30, 2024 | 177.02% |
| Jun 30, 2024 | 378.94% |
| Mar 31, 2024 | 105.46% |
| Dec 31, 2023 | 137.85% |
| Sep 30, 2023 | 21.38% |
| Jun 30, 2023 | -23.93% |
| Mar 31, 2023 | -194.58% |
| Dec 31, 2022 | -459.52% |
| Sep 30, 2022 | 68.41% |
| Jun 30, 2022 | -45.51% |
| Mar 31, 2022 | 81.68% |
| Dec 31, 2021 | -95.85% |
| Sep 30, 2021 | 73.82% |
| Jun 30, 2021 | 97.99% |
| Mar 31, 2021 | -262.19% |